Legal & General Group Plc - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 55 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$419,033
+23.6%
24,124
+0.2%
0.00%
Q2 2023$338,890
+153.5%
24,069
+93.7%
0.00%
Q1 2023$133,693
-23.8%
12,425
+6.1%
0.00%
Q4 2022$175,445
+26.2%
11,712
+7.8%
0.00%
Q3 2022$139,000
+35.0%
10,862
+1.4%
0.00%
Q2 2022$103,000
+21.2%
10,714
+25.3%
0.00%
Q1 2022$85,000
-15.8%
8,5520.0%0.00%
Q4 2021$101,000
+4.1%
8,5520.0%0.00%
Q3 2021$97,000
+83.0%
8,552
+123.9%
0.00%
Q2 2021$53,000
-35.4%
3,820
-13.6%
0.00%
Q1 2021$82,000
+7.9%
4,421
+3.0%
0.00%
Q4 2020$76,000
+15.2%
4,2910.0%0.00%
Q3 2020$66,000
-38.9%
4,291
+0.7%
0.00%
Q2 2020$108,000
+272.4%
4,262
+87.2%
0.00%
Q1 2020$29,000
-14.7%
2,277
-26.4%
0.00%
Q4 2019$34,000
+54.5%
3,092
+21.0%
0.00%
Q3 2019$22,000
-37.1%
2,5550.0%0.00%
Q2 2019$35,000
-2.8%
2,555
+28.4%
0.00%
Q1 2019$36,000
+28.6%
1,990
+103.1%
0.00%
Q4 2018$28,000
+12.0%
9800.0%0.00%
Q3 2018$25,0009800.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders